Company Data
Mineralys Therapeutics Inc.
Ticker
MLYS
Current Price
$20.3 -6.19%
Market Cap
$1.8B
Price Target
Refer to Report
Volume
1.2M
52wk Range
$20.41 - $47.65
Overview
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.